Edoxaban: Completed Phase III enrollment

Daiichi Sankyo completed enrollment of more than 8,250 patients who have had an acute symptomatic DVT, PE or both in the double-blind, international Phase III Hokusai-VTE trial comparing 60 mg oral ed...